Detalles de la búsqueda
1.
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.
BMC Cancer
; 15: 352, 2015 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935541
Resultados
1 -
1
de 1
1
Próxima >
>>